HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The Thomsen-Friedenreich Antigen-Specific Antibody Signatures in Patients with Breast Cancer.

Abstract
Alterations in the glycosylation of serum total immunoglobulins show these antibodies to have a diagnostic potential for cancer but the disease-related Abs to the tumor-associated antigens, including glycans, have still poorly been investigated in this respect. We analysed serum samples from patients with breast carcinoma (n = 196) and controls (n = 64) for the level of Thomsen-Friedenreich (TF) antigen-specific antibody isotypes, their sialylation, interrelationships, and the avidity by using ELISA with the synthetic TF-polyacrylamide conjugate as an antigen and the sialic acid-specific Sambucus nigra agglutinin (SNA) and ammonium thiocyanate as a chaotrope. An increased sialylation of IgG and IgM, but a lower SNA reactivity of IgA TF antibodies, and a higher level and avidity of the TF-specific IgA were found in cancer patients. Other cancer-related signatures were the highly significant increase of the IgG/IgA ratio and the very low SNA/IgA index in cancer, including patients with an early stage of the disease. These changes showed a good diagnostic potential with about 80% accuracy. Thus, the level of naturally occurring anti-TF antigen antibodies, their sialylation profile, isotype distribution, and avidity displayed cancer-specific changes that could serve as novel noninvasive Ab-based biomarkers for early breast cancer.
AuthorsOleg Kurtenkov, Kaire Innos, Boris Sergejev, Kersti Klaamas
JournalBioMed research international (Biomed Res Int) Vol. 2018 Pg. 9579828 ( 2018) ISSN: 2314-6141 [Electronic] United States
PMID30105268 (Publication Type: Journal Article)
Chemical References
  • Agglutinins
  • Antigens, Tumor-Associated, Carbohydrate
  • Thomsen-Friedenreich antigen
Topics
  • Adult
  • Aged
  • Agglutinins
  • Antigens, Tumor-Associated, Carbohydrate (analysis)
  • Breast Neoplasms (diagnosis, immunology)
  • Female
  • Humans
  • Middle Aged
  • Neoplasm Staging
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: